New findings highlight potential advantages of MIRA’s novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL / July 22, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a leading pre-clinical-stage pharmaceutical company, […]
Executives gather with Industry Leaders to Discuss Energy Transition, Enabling Technologies, and Introduce New Market GM DANBURY, Conn., July 11, 2024 — FuelCell Energy, Inc., (Nasdaq: FCEL) held a pivotal event in Seoul on June […]
CARDIFF, UK July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is making good progress with eRapa™, […]
GBM AGILE trial data shows clinically meaningful improvement in a prespecified secondary analysis for overall survival in paxalisib-treated, newly diagnosed unmethylated patients with glioblastoma SYDNEY, July 10, 2024 — Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused […]
Deploying commercially available solutions for Offshore Energy customers MONROE TOWNSHIP, N.J., July 02, 2024– Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, […]
Full year revenue of $46.7 million, up from $13.5 million in the prior year, a 245% increase. Net loss of $99.7 million is impacted by non-cash, non-recurring and extraordinary items, resulting in an Adjusted EBITDA1 loss […]
LEHI, Utah, July 01, 2024 — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR), a leading solar technology, services, and installation company, today announced that it had cancelled $67.6 million in debt from […]
GLENDALE, Calif., June 27, 2024—-Loop Media, Inc. (“Loop Media”) (NYSE American: LPTV), a leading multichannel streaming CTV platform that provides curated music videos, sports highlights, news, premium entertainment channels, and digital signage for businesses, and […]
$8M grant supports ongoing Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia SOUTH SAN FRANCISCO, Calif., July 01, 2024 — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti […]
FREMONT, Calif., June 25, 2024 — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced it has signed an agreement with a leading California-based technology company to provide silicon batteries and packs for […]
Refinancing reduces outstanding debt by more than $80 million, saving ~$7 million in cash interest annually and accelerating Regis’ investment in long-term growth Supplemental Presentation Available on the Regis Investor Relations Website MINNEAPOLIS, June 25, […]
− Achieved 28% and 33% Reduction in Composite of All-Cause Mortality and Recurrent Cardiovascular Events in the Overall and Monotherapy Populations, Respectively – − Reduced All-Cause Mortality by 36% and 35% in the Overall and […]
Significant strategic investment supports Company’s growth plans in an accelerating long duration battery storage market and enables Eos to restructure existing debt TURTLE CREEK, Pa. and NEW YORK, June 24, 2024 — Eos Energy Enterprises, […]
ZIBO, China, June 24, 2024 — Sunrise New Energy Co., Ltd. (“Sunrise New Energy”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced the successful delivery of 5,800 tons of energy storage material to Xiamen […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
